Updates in early stage non-small cell lung cancer
1 Views
administrator
07/14/23
Alessandra Bearz, MD, CRO National Cancer Institute, Aviano, Italy, discusses key updates in early-stage non-small cell lung cancer, higlighting the role of chemotherapy and immunotherapy in the adjuvant and neoadjuvant settings as well as treatment sequencing in patients with actionable mutations. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.
-
Category
Show more
Facebook Comments
No comments found